Leibniz Institute on Aging - Fritz Lipmann Institute

What Leibniz Institute on Aging - Fritz Lipmann Institute does

FLI is a publicly funded, non-university biomedical research institute headquartered in Jena, Germany, founded in 2004 as Germany's first research institute dedicated to biological aging. The institute investigates the molecular, cellular, and systems-level mechanisms underlying aging and age-related diseases, operating through two principal program areas — Program Area 1 (Molecular and Cellular Mechanisms of Aging) and Program Area 2 (Integrative Molecular Physiology) — and employing approximately 350 staff from roughly 40 nations across science and science-support functions.

The institute's research stack combines evolutionary approaches with diverse model systems and cutting-edge omics technologies, supported by an in-house network of core facilities, core services, animal facilities, and specialized units. Notable proprietary assets include the AEGIS tool for studying the evolution of aging and lifespan, and a joint PhD training program (Leibniz Graduate School on Aging, LGSA) co-run with Friedrich Schiller University Jena. Research outputs are disseminated globally through peer-reviewed publications, scientific conferences, public lecture series, and educational events such as the Science & Society series, Long Night of Sciences, and MINT Festival.

FLI's revenue model is non-commercial: it is financed primarily by joint institutional funding from the German Federal Government and the State of Thuringia as a member of the Leibniz-Gemeinschaft (Leibniz Association), supplemented by competitive project grants (including LIFE "Connect" with Jena University Hospital and the German Center for Mental Health). Customer segments are the global scientific research community, PhD candidates and early-career researchers, and the general public engaged through outreach programming; the institute charges no commercial fees for its research outputs.

Name

Leibniz Institute on Aging - Fritz Lipmann Institute

Legal name

Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V.

Website

https://leibniz-fli.de

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

FLI is Germany's first dedicated biomedical aging research institute, conducting basic research on molecular, cellular, and systems-level mechanisms of aging and age-related diseases, funded primarily by the German Federal Government and the State of Thuringia as a Leibniz Association member.

Ownership category

akta.pro rank

Headquarters

HQ city

Jena

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

1. Government funding: FLI is jointly funded by the German Federal Government and the State of Thuringia as a member of the Leibniz-Gemeinschaft (Leibniz Association). This is the primary funding source for the institute's research operations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

FLI is a non-profit biomedical research institute that investigates the molecular, cellular, and systems-level mechanisms of aging and age-related diseases. It organizes its science into two Program Areas and supports researchers with core facilities, omics technologies, and animal facilities. It also runs the Leibniz Graduate School on Aging (LGSA) PhD training program jointly with Friedrich Schiller University Jena.

Product overview

FLI is a biomedical research institute focused on the biology of aging, conducting research at the molecular, cellular, and systems levels. The institute operates two main Program Areas: Program Area 1 (Molecular and Cellular Mechanisms of Aging) and Program Area 2 (Integrative Molecular Physiology). It provides research infrastructure through core facilities, core services, and specialized units. The Leibniz Graduate School on Aging (LGSA), a joint program with Friedrich Schiller University Jena, offers PhD training in aging research. The institute does not offer commercial products but provides research services, training programs, and scientific collaboration opportunities.

Differentiator

Problem solved

Functional benefit

Products and services

• Leibniz Graduate School on Aging (LGSA)
• Program Area 1 - Molecular and Cellular Mechanisms of Aging
• Program Area 2 - Integrative Molecular Physiology
• Research Infrastructure (Core Facilities and Services)
• International Welcome Center

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Friedrich Schiller University (FSU) JenacoreStrategic or Co-development Partner · 1 January 2006Joint program through the Leibniz Graduate School on Aging (LGSA), providing PhD training and research opportunities in the field of aging research. The LGSA is a cornerstone of FLI's educational mission.
• Leibniz AssociationcoreStrategic or Co-development PartnerFLI is a member of the Leibniz-Gemeinschaft, a network of non-university research institutions. This provides institutional framework, evaluation processes, and access to collaborative networks within the German research landscape.
• Jena University Hospital / German Center for Mental Health (DZPG)minorStrategic or Co-development PartnerCollaboration on project funding through LIFE 'Connect' grant program for research on multimodal molecular signaling pathways in depression and neuropsychiatric post-COVID syndrome.
• Dual Career-Netzwerk MitteldeutschlandminorStrategic or Co-development PartnerFLI is a member of this regional network supporting Dual Career couples in Central Germany.
• Jenaer Bündnis für FamilieminorStrategic or Co-development PartnerFLI is a member of this local alliance working on family-friendly policies and work-life balance initiatives.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Babraham Institute: The Babraham Institute is a UK government-funded (BBSRC) biosciences institute focused on epigenetics, signalling, and ageing biology. It mirrors FLI's model of a publicly funded institute with research infrastructure, core facilities, and graduate training, though Babraham's portfolio is broader than FLI's ageing focus.
• Salk Institute for Biological Studies: Salk is a large, broad-based biomedical research institute conducting basic research across ageing, neuroscience, cancer, and plant biology. It is comparable to FLI in operating model (non-profit research institute, no undergraduates, mix of basic and disease-relevant research) but operates at much larger scale across multiple biological disciplines rather than specializing exclusively in ageing.

Direct peers

• Buck Institute for Research on Aging: The Buck Institute is the largest independent US biomedical research institute solely focused on ageing and age-related disease, using model systems and geroscience approaches. While privately funded rather than government-funded, it shares FLI's research model: interdisciplinary basic research on mechanisms of ageing with strong graduate/postdoc training components and no clinical care delivery.
• Paul F. Glenn Center for Biology of Aging Research at MIT: The Glenn Center at MIT is a flagship US ageing biology research hub embedded in MIT's Department of Biology, focusing on molecular mechanisms of ageing. Although university-based rather than a standalone institute, it targets the same scientific questions as FLI (genetics, cellular ageing, neurodegeneration) and competes for international grants, postdocs, and publication impact.
• Albert Einstein College of Medicine Institute for Aging Research: Einstein's Institute for Aging Research conducts basic and translational research on molecular biology of ageing, including genomics of longevity and neurodegeneration. It is comparable to FLI's program area on Molecular and Cellular Mechanisms of Aging and competes for NIH funding and international ageing biology collaborations.
• Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD): CECAD at the University of Cologne is a major German research consortium on ageing and age-associated diseases, sharing FLI's German public-funding base, model-organism approach, and geroscience focus. It is a directly comparable academic cluster in terms of scientific scope, funding mechanisms, and competitive positioning in the European ageing research landscape.
• Mayo Clinic Kogod Center on Aging: The Kogod Center at Mayo Clinic focuses on cellular senescence, ageing biology, and translation to age-related disease, combining basic research with clinical adjacent resources. It is comparable to FLI in scientific scope (molecular and cellular ageing mechanisms) but is anchored in a clinical enterprise, offering FLI a useful translational comparison point.
• Max Planck Institute for Biology of Ageing: The Max Planck Institute for Biology of Ageing in Cologne is Germany's other major publicly funded institute dedicated to molecular ageing research, operating with a similar Leibniz/MPG-scale structure, core facility model, and graduate training programs. It is the closest geographic and thematic peer to FLI and competes directly for talent, grants, and journal visibility in ageing biology.

Regional players

• Karolinska Institutet Department of Biosciences and Nutrition (BioNut): Karolinska Institutet's ageing and molecular medicine groups conduct biomedical ageing research comparable to FLI's Program Areas, but are embedded in a larger Swedish university medical setting. Regionally it competes with FLI for European ageing biology talent and Horizon/DFG funding, but operates under the Swedish funding system.

Others

• Leibniz Institute for Research on Evolution and Biodiversity: Other Leibniz Association institutes share FLI's funding and governance structure (joint federal/state funding, eV status, Leibniz evaluation framework), making them adjacent ecosystem peers for benchmarking governance, scale, and funding mechanics even though their scientific focus (e.g., marine biodiversity) differs from FLI's ageing biology mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCXnM4LC5LJRJzTNyvlUbYWQ
• LinkedInlinkedin.com/company/leibniz-institute-for-age-research---fritz-lipmann-institute-fli
• Instagraminstagram.com/flipmanns_azubis
• Xx.com/leibnizfli

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leibniz Institute on Aging - Fritz Lipmann Institute